Westport Innovations Rallies on Acquisition Chatter and 3 Stock Analyses Making Rounds

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Current Price: $57.18

William Blair has increased the company’s price target due to increased confidence in BMN-701 after the Lysosomal Disease Network WORLD Symposium. The firm still names BioMarin as a top pick for 2013 and reiterates its Outperform rating on stock.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

Capture

Digital Realty Trust Inc. (NYSE:DLR): Current Price: $63.22

JMP Securities is convinced that recent concerns about Digital Realty caused a compelling entry point in the stock and the firm is upbeat in regards to the long-term outlook for data center demand. The firm keeps its Outperform rating and a $75 price target on the stock.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

Capture

Westport Innovations Inc. (NASDAQ:WPRT): Current Price: $31.42

According to JPMorgan, Westport Innovations shares rallied on Friday resulting from a report that Cummins (NYSE:CMI) is considering an acquisition of the company at $42 per share. The firm believes that the potential deal is highly unlikely and adds that the $42 per share price makes little sense. JPMorgan reiterates its Neutral rating on the stock.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

Capture

CapLease, Inc. (NYSE:LSE): Current Price: $6.11

The company provided weaker than expected guidance, but JMP Securities continues to believe that CapLease is one of the more compelling investment opportunities across the REIT sector as a result of what the firm believes is its strong execution. The firm believes that the stock’s multiple will expand and it keeps its Outperform rating.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

Capture

Don’t Miss: Here’s What is Behind This German Minister’s Positive Outlook for the EU.